Organigram
now represented on American Trade Association for Cannabis and
Hemp, Policy Center for Public Health and Safety and European
Alliance for Medical Cannabis
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent
company of Organigram Inc. (the “Company” or “Organigram”), a
leading licensed producer of cannabis, is pleased to announce that
a representative of the Company has assumed board positions with
three international organizations committed to promote and foster
global cannabis industry growth: The American Trade Association for
Cannabis and Hemp, The Policy Center for Public Health & Safety
(both U.S.-based) and the European Alliance for Medical
Cannabis.
The Company’s Vice President of Public Affairs and Stakeholder
Relations (North America), Cameron Bishop, has assumed board seats
on all three associations, including a board chair position on the
European Alliance for Medical Cannabis’ Access, Innovation and
Research Committee.
In addition, Mr. Bishop was recently appointed vice-chair of the
Cannabis Council of Canada (C3), Canada’s national organization of
licensed producers.
“I’m proud to represent Organigram and the legal cannabis
industry in Canada as a board member for these organizations.
Reforming cannabis laws, breaking down barriers of prohibition and
building new economic engines takes time, dedication and
experience,” Bishop said. “These groups embody those elements; I’m
confident the work we do together will lead to lasting benefits for
cannabis, industry, consumers and patients here at home and around
the world.”
Organigram’s invitation to participate in a directorial capacity
for the groups – each regarded as a respected industry advocacy and
thought leader in its respective region – is a testament to the
Company’s reputation among its peers in foreign markets.
The Policy Center for Public Health & Safety (“PH&S”)
was founded to facilitate constructive dialogue on state-legalized
cannabis issues among state attorneys general and state, federal,
and international regulators. The group is currently expanding its
effort given recent dialogue with United States law enforcement,
State Attorneys General and Canadian officials regarding American
companies trading on public stock exchanges relating to
cross-border investment activity and the legal status of
hemp-derived CBD.
"Organigram brings an invaluable global perspective to The
Policy Center for Public Health & Safety and we are honored to
have the Company as part of our team,” said Policy Center for
Public Health & Safety Chair Fred Niehaus. “In the rapidly
evolving business and regulatory environment surrounding the
cannabis industry, it is essential to have representatives who are
both knowledgeable and credible. Organigram embodies that. Mr.
Bishop’s thoughtful interaction with stakeholders will serve the
industry well.”
The European Alliance for Medical Cannabis’ mission is to
represent, defend and promote the European medicinal cannabis
sector and help members achieve sustainable business growth. In
addition to board membership, Mr. Bishop assumes a board chair
position on the European Alliance for Medical Cannabis’ Access,
Innovation and Research Committee.
The American Trade Association for Cannabis & Hemp’s
mandates include promoting the expansion and protection of legal
sales of cannabis and hemp for industrial, medical and adult
use.
“The American Trade Association for Cannabis & Hemp
("ATACH") is thrilled to welcome Organigram, one of the world's
leading cannabis companies, as a member and to appoint Mr. Cameron
Bishop to ATACH's board of directors,” said ATACH President Michael
Bronstein. “Mr. Bishop is one of the most respected names in
Canadian cannabis and the international perspective Organigram
provides to our organization as the United States considers a
federally legal marketplace will be invaluable.”
About American Trade Association for Cannabis and
Hemp:
The American Trade Association for Cannabis and Hemp (ATACH) is
the leading 501(c)(6) marijuana industry trade organization
promoting the expansion and protection of legal sales of marijuana
and hemp for industrial, medical, and adult use. ATACH had been
named “Trade Association of the Year” and “Corporate Grassroots
Organization of the Year” by Campaigns & Elections magazine.
ATACH’s membership is comprised of the largest and most influential
businesses in the industry and promotes the protection and
expansion of the cannabis industry.
About The Policy Center for Public Health &
Safety:
The Policy Center for Public Health & Safety (PH&S) is a
public policy organization which collaborates closely with state
attorneys general. The organization was developed to formalize work
PH&S has conducted on behalf of AG organizations for the past 6
years and was founded with input from and the perspective of the
states, policy makers and regulators. The primary focus of PH&S
is dealing in the world of cannabis and hemp from four perspectives
which are of fundamental importance to law-enforcement and
attorneys general. Anti-money laundering, public health and safety,
consumer protection and rule of law. These are part of the
constitutional charges of state attorneys general. The Policy
Center is involved with facilitating dialogue and policy discussion
surrounding the conflicting aspects of the legalization efforts in
particular, the recent impacts of the 2018 US Farm Bill addressing
hemp and CBD production and distribution.
About Organigram Holdings Inc.:
Organigram Holdings Inc. is a NASDAQ Global Select and TSX
listed company whose wholly owned subsidiary, Organigram Inc., is a
licensed producer of cannabis and cannabis-derived products in
Canada.
Organigram is focused on producing high-quality, indoor-grown
cannabis for patients and adult recreational consumers in Canada,
as well as developing international business partnerships to extend
the Company's global footprint. Organigram has also developed a
portfolio of legal adult use recreational cannabis brands including
The Edison Cannabis Company, Ankr Organics and Trailblazer.
Organigram's primary facility is located in Moncton, New Brunswick
and the Company is regulated by the Cannabis Act and the Cannabis
Regulations (Canada).
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “expects”, “estimates”,
“intends”, “anticipates”, “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information including
risks as disclosed in the Company’s most recent annual information
form, management’s discussion and analysis and other Company
documents filed from time to time on SEDAR (see www.sedar.com) and
filed or furnished to the Securities and Exchange Commission on
EDGAR (see www.sec.gov). Readers are cautioned not to place undue
reliance on these forward-looking statements, which speak only as
of the date of this press release. Although the Company believes
that the assumptions and factors used in preparing the
forward-looking information in this news release are reasonable,
undue reliance should not be placed on such information and no
assurance can be given that such events will occur. The
forward-looking information included in this news release are made
as of the date of this news release and the Company disclaims any
intention or obligation, except to the extent required by law, to
update or revise any forward-looking information, whether as a
result of new information, future events or otherwise. We seek safe
harbor.
For more information about Organigram please visit
www.Organigram.ca
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191007005266/en/
For Investor Relations enquiries, please contact: Amy Schwalm
Vice President, Investor Relations, Organigram Inc.
Amy.Schwalm@organigram.ca (416)
704-9057
For media enquiries, please contact: Ray Gracewood Senior Vice
President, Marketing and Communications, Organigram Inc.
rgracewood@organigram.ca (506) 645-1653
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Sep 2023 to Sep 2024